• 1
    Burdelski M, Ullrich K. Liver transplantation in metabolic disorders: Summary of the general discussion. Eur J Pediatr 1999; 158(suppl 2):S95S96. MEDLINE
  • 2
    Danpure CJ. Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. FEBS Lett 1986; 201:2024. MEDLINE
  • 3
    Morgan SH, Purkiss P, Watts RWE, Mansell MA. Oxalate dynamics in chronic renal failure. Comparison with normal subjects and patients with primary hyperoxaluria. Nephron 1987; 46:253257. MEDLINE
  • 4
    Latta K, Brodhel J. Primary hyperoxaluria type I. Eur J Pediatr 1990; 149:518522. MEDLINE
  • 5
    Cochat P, Deloraine A, Rotily M, Olive F, Liponski I, Deries N, et al. Epidemiology of primary hyperoxaluria type I. Nephrol Dial Transplant 1995; 10(suppl 8):S3S7.
  • 6
    Williams H, Smith LH. L-Glyceric aciduria: A new genetic variant of primary hyperoxaluria. N Engl J Med 1968; 278:233239. MEDLINE
  • 7
    Giafi CF, Rumsby G. Primary hyperoxaluria type 2: Enzymology. J Nephrol 1998; 11(suppl 1):S29S31.
  • 8
    Wilson RE. A report from the ACS/NIH renal transplant registry. Renal transplantation in congenital and metabolic disease. JAMA 1975; 232:148153. MEDLINE
  • 9
    Watts RWE, Veall N, Purkiss P. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure. Clin Sci 1984; 66:591597. MEDLINE
  • 10
    Katz A, Kim Y, Scheinman J, Najarian JS, Mauer SM. Long-term outcome of kidney transplantation in children with oxalosis. Transplant Proc 1989; 21:20332035. MEDLINE
  • 11
    Broyer M, Brunner FP, Brynger H, Dykes SR, Ehrich JHH, Fassbinder W, et al. Kidney transplantation in primary oxalosis: Data from the EDTA Registry. Nephrol Dial Transplant 1990; 5:332336. MEDLINE
  • 12
    Jamieson NV. The results of combined liver/kidney transplantation for primary hyperoxaluria (PH1) 1984–1997. The European PH1 transplant registry report. J Nephrol 1998; 11(suppl 1):S36S41.
  • 13
    Saborio P, Scheinman JI. Transplantation for primary hyperoxaluria in the United States. Kidney Int 1999; 56:10941100. MEDLINE
  • 14
    Watts RWE, Calne RY, Williams R, Mansell MA, Veall N, Purkiss P, et al. Primary hyperoxaluria (type I): Attempted treatment by combined hepatic and renal transplantation. Q J Med New Series 1985; 57:697703.
  • 15
    Watts RWE, Rolles K, Morgan SH, Williams R, Calne RY, Danpure CJ, et al. Successful treatment of primary hyperoxaluria type I by combined hepatic and renal transplantation. Lancet 1987; 2:474475. MEDLINE
  • 16
    Scheinman JI, Najarian JS, Mauer SM. Successful strategies for renal transplantation in primary oxalosis. Kidney Int 1984; 25:804811. MEDLINE
  • 17
    Milliner DS, Wilson DM, Smith LH. Phenotypic expression of primary hyperoxaluria: Comparative features of types I and II. Kidney Int 2001; 59:3136. MEDLINE
  • 18
    Williams HE, Smith LH. Hyperoxaluria in L-glyceric aciduria: Possible pathogenic mechanism. Science 1971; 171:390391. MEDLINE
  • 19
    Giafi CF, Rumsby G. Kinetic analysis and tissue distribution of human D-glycerate dehydrogenase/glyoxylate reductase and its relevance to the diagnosis of primary hyperoxaluria type 2. Ann Clin Biochem 1998; 35:104109. MEDLINE
  • 20
    Williams AW, Smith LH, Wilson DM, Milliner DS, Hart G, McCarthy JT. Removal of oxalate with hemodialysis in ESRD patients with primary hyperoxaluria (PH) [abstract]. J Am Soc Nephrol 1992; 3:690A.
  • 21
    Milliner DS, Eickholt BS, Bergstralh MS, Wilson DM, Smith LH. Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med 1994; 331:15531558. MEDLINE
  • 22
    Olthuis FM, Markslag AM, Klein-Elhorst JT, Krugers-Dagneaux PG. Urinary oxalate estimation. Clin Chim Acta 1977; 75:123128. MEDLINE
  • 23
    Wilson DM, Liedtke RR. Modified enzyme-based colorimetric assay of urinary and plasma oxalate with improved sensitivity and no ascorbate interference: Reference value and sample handling procedures. Clin Chem 1991; 37:12291235. MEDLINE
  • 24
    Ott NT, Wilson DM. A simple technique for estimating glomerular filtration rate with subcutaneous injection of [125I] iothalamate. Mayo Clin Proc 1975; 50:664668. MEDLINE
  • 25
    Allsop J, Jennings PR, Danpure CJ. A new micro-assay for human liver alanine:glyoxylate aminotransferase. Clin Chim Acta 1987; 170:187193. MEDLINE
  • 26
    Mistry J, Danpure CJ, Chalmers RA. Hepatic D-glycerate dehydrogenase and glyoxylate reductase deficiency in primary hyperoxaluria type 2. Biochem Soc Trans 1988; 16:626627.
  • 27
    Rumsby G, Weir T, Samuell CT. A semiautomated alanine:glyoxylate aminotransferase assay for the tissue diagnosis of primary hyperoxaluria type I. Ann Clin Biochem 1997; 34:400404. MEDLINE
  • 28
    Barratt TM, Danpure CJ. Hyperoxaluria. In: BarrattTM, AvnerED, HarmonWE (eds). Pediatric nephrology (ed 4). Baltimore: Lippincott Williams & Wilkins, 1999:609619.
  • 29
    Cramer SD. Molecular genetics of primary hyperoxaluria type 2 [abstract]. Oxalosis and Calcium Oxalate Stone Disease, Columbia, MD, November 16–17, 2000.
  • 30
    Rumsby G. Biochemical and genetic diagnosis of the primary hyperoxalurias: A review. Mol Urol 2000; 4:349353. MEDLINE
  • 31
    Cramer SD, Ferree PM, Lin K, Milliner DS, Holmes RP. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. Hum Mol Genet 1999; 8:20632069. MEDLINE
  • 32
    Webster KE, Ferree PM, Holmes RP, Cramer SD. Identification of missense, nonsense, and deletion mutations in the GRHPR gene in patients with primary hyperoxaluria type II (PH2). Hum Genet 2000; 107:176185. MEDLINE
  • 33
    Schurmann G, Scharer K, Wingen AM, Otto G, Herfarth C. Early liver transplantation for primary hyperoxaluria type 1 in an infant with chronic renal failure. Nephrol Dial Transplant 1990; 5:825827. MEDLINE
  • 34
    Ellis SR, Hulton SA, McKiernan PJ, de Ville de Goyet J, Kelly DA, et al. Combined liver-kidney transplantation for primary hyperoxaluria type 1 in young children. Nephrol Dial Transplant 2001; 16:348354. MEDLINE
  • 35
    Danpure CJ. Scientific rationale for hepatorenal transplantation in primary hyperoxaluria type 1. Amsterdam:Excerpta Medica, 1991.
  • 36
    Danpure CJ. Primary hyperoxaluria. In: ScriverCR, BeaudetAL, SlyWS, ValleD (eds). The metabolic and molecular bases of inherited disease (ed 8). New York: McGraw-Hill. 2001; volume 2:33233367.
  • 37
    Gruessner RW. Preemptive liver transplantation from a living related donor in primary hyperoxaluria type I. N Engl J Med 1998; 338:1924. MEDLINE
  • 38
    Toussaint C. Pyridoxine-responsive PH1: Treatment. J Nephrol 1998; 11(suppl 1):S49S50.
  • 39
    Marangella M. Transplantation strategies in type I primary hyperoxaluria: The issue of pyridoxine responsiveness. Nephrol Dial Transplant 1999; 14:301303. MEDLINE
  • 40
    Schaumburg H, Kaplan J, Windebank A, Vick N, Rasmus S, Pleasure D, et al. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med 1983; 309:445448. MEDLINE
  • 41
    Watts RWE, Morgan SH, Danpure CJ, Purkiss P, Calne RY, Rolles K, et al. Combined hepatic and renal transplantation in primary hyperoxaluria type I: Clinical report of nine cases. Am J Med 1991; 90:179188. MEDLINE
  • 42
    Worcester EM, Nakagawa Y, Bushinsky DA, Coe FL. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure. J Clin Invest 1986; 77:18881896. MEDLINE
  • 43
    Marangella M, Petrarulo M, Vitale C, Daniele PG, Sammartano S, Cosseddu D, et al. Serum calcium oxalate saturation in patients on maintenance haemodialysis for primary hyperoxaluria or oxalosis-unrelated renal diseases. Clin Sci 1991; 81:483490. MEDLINE
  • 44
    Hoppe B, Kemper MJ, Bokenkamp A, Langman CB. Plasma calcium-oxalate saturation in children with renal insufficiency and in children with primary hyperoxaluria. Kidney Int 1998; 54:921925. MEDLINE
  • 45
    Marangella M, Cosseddu D, Petrarulo M, Vitale C, Linari F. Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria. Nephrol Dial Transplant 1993; 8:13331337. MEDLINE
  • 46
    Watts RWE, Veall N, Purkiss P. Sequential studies of oxalate dynamics in primary hyperoxaluria. Clin Sci 1983; 65:627633. MEDLINE
  • 47
    Milliner DS, Wilson DM, Smith LH. Clinical expression and long-term outcomes of primary hyperoxaluria types 1 and 2. J Nephrol 1998; 11(suppl 1):S56S59.
  • 48
    Burdelski M, Nolkemper D, Ganschow R, Sturm E, Malago M, Rogiers X, et al. Liver transplantation in children: Long-term outcome and quality of life. Eur J Pediatr 1999; 158(suppl 2):S34S42. MEDLINE